Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator^TM micro-MLC: A dosimetric analysis

References

• Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 2009;93:185–91.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJ, Slot A, Dielwart MF, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:980–8.
   PubMed Web of Science ®Google Scholar
• Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010;78:11–8.
   PubMed Web of Science ®Google Scholar
• Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, et al. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: Results from a randomized trial. Int J Radiat Oncol Biol Phys 2014;88:1074–84.
   PubMed Web of Science ®Google Scholar
• Lukka H, Hayter C, Julian, JA, Warde P, Morris WJ, Gospodarowicz M, et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. Int J Clin Oncol 2005;23:6132–8.
   Web of Science ®Google Scholar
• Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 2013;31:3860–8.
   PubMed Web of Science ®Google Scholar
• Yeoh EE, Botten RJ, Butters J, Di Matteo AC, Holloway RH, Fowler J. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial. Int J Radiat Oncol Biol Phys 2011;81:1271–8.
   PubMed Web of Science ®Google Scholar
• Dearnaley D, Syndikus I, Sumo G, Bidmead M, Bloomfield D, Clark C, et al. Conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol 2012;13:43–54.
   PubMed Web of Science ®Google Scholar
• Carosi A, Ingrosso G, Ponti E, Tolu B, Murgia A, di Cristino D, et al. Dosimetric effect of Elekta Beam modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Med Dosim 2014;39:180–4.
   PubMed Web of Science ®Google Scholar
• Wang L, Hoban P, Paskalev K, Yang J, Li J, Chen L, et al. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy. Med Dosim 2005;30:97–103.
   PubMed Web of Science ®Google Scholar
• Patel L, Glendinning AG, Kirbi MC. Dosimetric characteristics of the Elekta Beam ModulatorTM. Phys Med Biol 2005; 50:5479–92.
   PubMed Web of Science ®Google Scholar
• Ingrosso G, Carosi A, Ponti E, Murgia A, di Cristino D, Barbarino R, et al. Acute and late toxicity after three- dimensional conformal image-guided radiotherapy for localized prostate cancer. Cancer Invest 2014;32:526–32.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6–13.
   PubMed Web of Science ®Google Scholar
• Michalsky JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76:S123–219.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010;76:S116–22.
   PubMed Web of Science ®Google Scholar
• Holm S. A simple sequential rejective multiple test procedure. Scand J Stat 1979;6:65–70.
   Web of Science ®Google Scholar
• Hegemann NS, Guckenberger M, Belka C, Ganswindt U, Manapov F, Li M. et al. Hypofractionated radiotherapy for prostate cancer. Radiat Oncol 2014;9:275.
   PubMed Web of Science ®Google Scholar
• Wong WM, Wallner KE. The case for hypofractionation of localized prostate. Cancer Rev Urol 2013;15:113–7.
   PubMedGoogle Scholar
• Koontz BF, Bossi A, Cozzarini C, Wiegel T, D’Amico A. A systematic review of hypofractionation for primary management of prostate cancer. Eur Urol Epub 2014 Aug 26. pii: S0302-2838(14)00751-9. doi: 10.1016/j.eururo.2014.08.009.
   Google Scholar
• Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J, et al. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 2007;69:1084–9.
   PubMed Web of Science ®Google Scholar
• Reddy NMS, Nori D, Chang H, Lange CS, Ravi A. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy. Med Phys 2010;37:3791–801.
   PubMed Web of Science ®Google Scholar
• Buckey C, Swanson G, Stathakis S, Papanikolaou N. Dosimetric comparison between 3D conformal and intensity-modulated radiation therapy for prostate cancer. J Radiat Pract 2010;9:77–85.
   Google Scholar